CAMP4 Therapeutics lands $30 mln Series A
Cambridge, Massachusetts-based CAMP4 Therapeutics, has raised $30 million in Series A funding. The investors included Polaris Partners, the Kraft Group and Andreessen Horowitz.
31 May 2018•1 min read
Cambridge, Massachusetts-based CAMP4 Therapeutics, has raised $30 million in Series A funding. The investors included Polaris Partners, the Kraft Group and Andreessen Horowitz.
